Hippo Pathway Screening
Hippo Pathway Screening - Related Videos
10:43
siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells
0 Views •
Cited by 3 •
2014
Here, we describe a methodology to perform a targeted siRNA “ubiquitome” screen to identify novel ubiquitin and ubiquitin-like regulators of the HIF1A-mediated cellular response to hypoxia. This can be adapted to any biological pathway where a robust read out of reporter activity is available.
08:50
Genetic Screens
0 Views •
2023
Genetic screens are critical tools for defining gene function and understanding gene interactions. Screens typically involve mutating genes and then assessing the affected organisms for phenotypes of interest. The process can be “forward”, where mutations are generated randomly to identify unknown genes responsible for the phenotypes, or it can be “reverse”, where specific genes are targeted for mutation to observe what phenotypes are produced.Here, JoVE reviews various types of genetic...
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
0 Views •
2015
Here we describe a cell-based reporter gene assay as a valuable tool to screen chemical libraries for compounds modulating post-transcriptional control mechanisms exerted through 3’ UTR.
07:40
Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens
0 Views •
Cited by 5 •
2019
Bacterial pathogens secrete proteins into the host that target crucial biological processes. Identifying the host pathways targeted by bacterial effector proteins is key to addressing molecular pathogenesis. Here, a method using a modified yeast suppressor and toxicity screen to elucidate host pathways targeted by toxic bacterial effector proteins is described.
08:10
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
0 Views •
Cited by 8 •
2016
This work presents a method of high-throughput screening using a universal genetic enzyme screening system that can be theoretically applied to over 200 enzymes. Here, the single screening system identifies three different enzymes (lipase, cellulase, and alkaline phosphatase) by simply changing the substrate used (p-nitrophenyl acetate, p-nitrophenyl-β-D-cellobioside, and phenyl phosphate).
FAQs
The kinase cascade places MST1/2 and LATS1/2 upstream of YAP and TAZ. When these kinases phosphorylate the transcriptional regulators, YAP and TAZ are driven toward cytoplasmic retention or degradation. Reduced phosphorylation instead permits nuclear accumulation, where they associate with TEAD and activate growth-supporting gene programs. This directionality lets a screen distinguish pathway activation from suppression.
Changes in both location and activity are informative. Reduced Hippo signaling allows YAP and TAZ to move into the nucleus, where they bind TEAD transcription factors and activate genes associated with proliferation and survival. Therefore, nuclear localization can indicate pathway status, while a corresponding transcriptional or growth response provides functional evidence that the signaling change affects cancer-relevant cell behavior.
Each readout captures a different level of pathway behavior. Reporter activity reflects transcriptional output, protein localization shows whether YAP or TAZ is cytoplasmic or nuclear, and phosphorylation reports kinase-linked regulation. Cell-growth measurements add a functional outcome. Using these complementary signals helps connect a molecular change with its downstream effect rather than relying on a single indicator.
A gene or protein candidate can point to a pathway regulator, whereas a compound can reveal a chemically influenced response. Cellular conditions test whether pathway behavior changes in a particular context. Comparing these intervention types with molecular and growth readouts helps identify factors that alter Hippo signaling and supports more detailed analysis of mechanisms relevant to cancer biology.
A basic workflow begins by selecting genes, proteins, compounds, or cellular conditions for testing. The intervention is evaluated with one or more Hippo-related assays, such as reporter activity, YAP or TAZ localization, phosphorylation, or cell growth. Researchers then compare the measured changes to determine whether the tested factor alters pathway signaling and its cellular consequences.
The assay should match the biological question. Reporter activity is useful for examining transcriptional output, localization reveals movement of YAP or TAZ between the cytoplasm and nucleus, and phosphorylation reflects regulation by the kinase cascade. Cell-growth measurements address the resulting cellular phenotype. Combining suitable readouts can connect pathway changes with proliferation or survival-related outcomes.
By linking pathway perturbations to molecular and cellular outcomes, Hippo pathway screening can identify regulators that may contribute to tumor development. It can also reveal whether altered YAP or TAZ signaling is associated with increased proliferation or survival, helping clarify cancer mechanisms. In therapeutic discovery, compound responses provide a way to investigate strategies aimed at YAP/TAZ or related pathway components.